Skip to main content
. 2018 Mar 27;9:565. doi: 10.3389/fmicb.2018.00565

Table 2.

Dinitrobenzene sulfonic acid (DNBS) doses employed in this study.

Experiments DNBS Dose
Trial 1: Inflammation patterns in CD-1 mice vs. Black-6 mice 200 mg/kg
2.7 mg—Black-6 females
3 mg—Black-6 males
4.1 mg—CD-1 females
4.3 mg—CD-1 males
Trial 2: Protocol optimization using CD-1 mice 3.5 mg/2.5 mg/1.5 mg